Avricore Health Inc. (AVCRF)
| Market Cap | 6.42M +24.8% |
| Revenue (ttm) | 135.94K -93.7% |
| Net Income | -1.27M |
| EPS | -0.01 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,000 |
| Open | 0.0250 |
| Previous Close | 0.0250 |
| Day's Range | 0.0008 - 0.0370 |
| 52-Week Range | 0.0008 - 0.0787 |
| Beta | 0.32 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Dec 2, 2026 |
About Avricore Health
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada. [Read more]
Financial Performance
In 2025, Avricore Health's revenue was 533,884, a decrease of -88.84% compared to the previous year's 4.79 million. Losses were -1.86 million, 177.8% more than in 2024.
Financial numbers in CAD Financial StatementsNews
HealthTab™ Programme Expands Nationally Across England
VANCOUVER, British Columbia, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that NHS England has confirmed the national expansion of the Barts Health pharm...
Avricore Grants Options
VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) today announces that the Company's board of directors has approved the granting of stock options (the “...
HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK
VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal colla...
Avricore Health Closes $1.254 Million Financing
VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces that, further to its news release dated May 20, 2026, the Compa...
Avricore Health Announces $1.25 Million Financing
VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) announces a non-brokered private placement of up to 25,000,000 units ("Uni...
Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform
VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) announces HealthTab™ has now screened more than 3,500 patients in commun...
HealthTab™ to Expand Across North East London
VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announced the planned expansion of its HealthTab™ platform across N...
Avricore Appoints Rodger Seccombe as CEO
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) is pleased to report the appointment of Rodger Seccombe as CEO of the Com...
AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its result for the first quarter of 2025 and its progress towa...
AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track
VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its year end 2024 and In the year ended December 31, 2024 reven...
HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK
VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) today announced its successful integration of HealthT...
Avricore Health Corporate Update: Effective Plan, Resources Result in Success
VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its third quarter results for 2024 where the Company continues...
Avricore Health Refocuses Strategy to Unlock Growth Potential
VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR) ("Avricore" or the "Company"), a leader in pharmacy-based point-of-care testing solutions, today annou...
Avricore Health Recognized in Deloitte's 2024 Technology Fast 50™ Companies to Watch
VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR), a leader in pharmacy-based health technology solutions, proudly announces its placement in Deloitte C...
Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability
VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its mid-year results for 2024 demonstrating the Company's cont...
Avricore Health Corporate Update and Audited Results for 2023
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce its audited results for 2023.
HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce further expansion of HealthTa...
Avricore Health Corporate Update – Company Demonstrates Strong Growth
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) reports on its third quarter results which demonstrate significant growth in ...
HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic
VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic an...
Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track
VANCOUVER, British Columbia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to achieve significant growth, new partnerships and developing new ...
HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion
VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a reseller agre...
Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
VANCOUVER, British Columbia, June 21, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) held its annual general meeting to elect directors, appoint its auditor and a...
Avricore Health Corporate Updates on Audited Results for 2022
The Company will host an investor update call on May 3rd with CEO Hector Bremner to share the Company's outlook and take questions The Company will host an investor update call on May 3rd with CEO Hec...
Avricore Health's HealthTab™ Passes 530 Locations, Adds Virus Detection
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching 532...
Avricore Health Makes the Grade on 2023 TSX Venture 50
VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) has been honoured by being named as one of the 2023 Venture 50, the TSX Ventu...